# Critic Review and Accepted Findings

Package: `jama.2025.9110`

Scope: Critic review was limited to the seven findings classified as `Verified` in
`.ai_paper_validation/verification/evidence_verification.md`. No new issues were
searched for. D02 and D03 were not opened, no external information was used, and
the source PDFs were not modified.

## Disposition summary

| Candidate | Critic disposition | Severity | Allowed category |
|---|---|---|---|
| C01 | Accepted | Minor | Arithmetic inconsistency |
| C02 | Accepted | Minor | Arithmetic inconsistency |
| C03 | Accepted | Minor | Presentation inconsistency |
| C04 | Accepted | Minor | Statistical reporting inconsistency |
| C05 | Accepted | Minor | Cross-document inconsistency |
| C06 | Uncertain; not accepted as a final issue | Uncertain | Statistical reporting inconsistency |
| C07 | Accepted | Minor | Presentation inconsistency |

Final accepted issues: **6**. Major: **0**. Minor: **6**. Uncertain and not
forwarded as a final issue: **1**. Rejected: **0**.

## Accepted final issues

### 1. Period 3 augmented-protein sex counts do not reconcile to the displayed denominator

- **Severity:** Minor
- **Category:** Arithmetic inconsistency
- **Exact location:** [D04, PDF p. 10, eTable 4, Period 3 - Augmented Protein, Sex rows](../../joi250040supp3_prod_1753124024.38098.pdf#page=10). Aggregate comparison: [D01, PDF p. 5, Table 1, Sex rows](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=5).
- **Source values/statements:** D04 gives the Period 3 augmented-protein column as `n = 551`, Male `359 (65.2)`, and Female `190 (34.5)`. The other augmented-protein period counts are Male `303`, `187`, and `220`, and Female `177`, `111`, and `132`. D01 Table 1 reports overall augmented-protein sex counts of Male `1070 (63.7)` and Female `611 (36.3)` among `n = 1681`. D04 provides no missing/other sex row or relevant footnote.
- **Calculation/logical basis:** `359 + 190 = 549`, two fewer than the displayed Period 3 denominator of `551`; the displayed percentages total `99.7%`. Across the four augmented-protein periods, the male counts total `303 + 187 + 359 + 220 = 1069` and the female counts total `177 + 111 + 190 + 132 = 610`, one fewer in each sex category than D01 Table 1. The finding is limited to the visible table reconciliation and does not infer the underlying participant values.
- **Critic rationale:** The count deficit is exact, independently corroborated by the aggregate table, and not explained in the displayed table. The issue appears local and does not affect a reported outcome or trial conclusion, so it is Minor.
- **Verification instruction:** Add the two Period 3 sex counts on D04 p. 10 and compare the result with `n = 551`; then sum each sex across the four augmented periods and compare with D01 Table 1 on p. 5. Confirm whether counts require correction or an omitted/missing category should be disclosed.

### 2. Protocol-deviation participant percentage matches the event count rather than the participant count

- **Severity:** Minor
- **Category:** Arithmetic inconsistency
- **Exact location:** [D04, PDF p. 16, eTable 8, Total protocol deviations, Augmented Protein column](../../joi250040supp3_prod_1753124024.38098.pdf#page=16).
- **Source values/statements:** Column denominator `n = 1681`; Number of participants with at least one event `151 (9.4)`; Number of events `158`.
- **Calculation/logical basis:** `151 / 1681 × 100 = 8.9827%`, which rounds to `9.0%` at one decimal. `158 / 1681 × 100 = 9.3992%`, which rounds to the displayed `9.4%`. Thus, the percentage printed beside the participant count numerically matches the separate event count.
- **Critic rationale:** The arithmetic is direct and the table distinguishes participants from events. This is a localized percentage error and is therefore Minor.
- **Verification instruction:** Recalculate `151/1681` and `158/1681` to one decimal and compare both results with the displayed `9.4%`; confirm whether the participant entry should read `151 (9.0%)`.

### 3. Figure 1 patient boxes use patient-level randomization wording although ICUs were randomized

- **Severity:** Minor
- **Category:** Presentation inconsistency
- **Exact location:** [D01, PDF p. 3, Figure 1, four patient-count treatment boxes](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=3). Comparison statements: [D01, PDF p. 2, Design/Trial Procedures](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=2) and [D01, PDF p. 8, Limitations](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=8).
- **Source values/statements:** Figure 1 says `1043 Randomized to augmented protein group`, `1015 Randomized to usual protein group`, `650 Randomized to augmented protein group and included in primary outcome analysis`, and `703 Randomized to usual protein group and included in the primary outcome analysis`. The Methods describe a `cluster randomized` trial, state that `ICUs were randomly assigned`, and say participants commenced the formula to which the ICU was randomized. The Limitations state that `randomization occurred at the cluster level rather than the patient level`.
- **Logical basis:** The four boxes grammatically attribute randomization to counted patients, while the article explicitly identifies the ICU/cluster as the randomized unit. The finding concerns the figure terminology only; the displayed participant counts and actual allocation process are not alleged to be wrong.
- **Critic rationale:** The source statements directly support a presentation mismatch, but the meaning remains recoverable from the surrounding figure and Methods. It is therefore Minor.
- **Verification instruction:** Compare the four patient-box labels on D01 p. 3 with the unit-of-randomization statements on pp. 2 and 8; assess replacing patient-level `Randomized to` wording with `Assigned/allocated to` or equivalent cluster-period language.

### 4. Bayesian primary-outcome row labels median/IQR values as mean (SD)

- **Severity:** Minor
- **Category:** Statistical reporting inconsistency
- **Exact location:** [D01, PDF p. 7, Table 2, Primary outcome (secondary analyses), Bayesian quantile mixed-model row](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7). Comparison: [D04, PDF p. 27, eFigure 6](../../joi250040supp3_prod_1753124024.38098.pdf#page=27).
- **Source values/statements:** The Bayesian quantile mixed-model outcome label ends with `mean (SD)`, but its treatment cells are `62.0 (0 to 77)` and `64.0 (0 to 77)` and its effect is `Median difference, -1.50 (-3.86 to 0.90)`. The primary row immediately above labels the same treatment summaries as `median (IQR)`. D04 eFigure 6 labels the Bayesian effect `Median Difference: -1.50 (95% CrI: -3.86, 0.90)`.
- **Calculation/logical basis:** The Bayesian row repeats the primary row's center, lower-quartile, and upper-quartile summaries while calling them `mean (SD)`, and both the model name and effect label identify a median analysis. The descriptive-statistic label is therefore inconsistent with the displayed values and analysis.
- **Critic rationale:** The inconsistency is explicit and internally corroborated, but it is a row-label error that does not change the displayed estimate or interval. It is Minor.
- **Verification instruction:** Read the full Bayesian row on D01 p. 7, compare its treatment cells with the primary row above, and confirm the effect label in D04 eFigure 6 on p. 27; determine whether `mean (SD)` should read `median (IQR)`.

### 5. Main-table ventilation summaries are labeled mean (SD) while the displayed format and supplement identify median (IQR) summaries

- **Severity:** Minor
- **Category:** Cross-document inconsistency
- **Exact location:** [D01, PDF p. 7, Table 2, Duration of invasive ventilation row](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7). Comparisons: [D04, PDF p. 18, eTable 10 and footer](../../joi250040supp3_prod_1753124024.38098.pdf#page=18) and [D04, PDF p. 4, eMethods, Duration of invasive ventilation](../../joi250040supp3_prod_1753124024.38098.pdf#page=4).
- **Source values/statements:** D01 labels the outcome `Duration of invasive ventilation, mean (SD), h` but displays `84.0 (35.0 to 178.9)` and `78.0 (33.2 to 161.0)`. D04 eTable 10 displays period-level ventilation summaries in the same three-number form and states, `Data presented as median (IQR) or n (%)`. D04 eMethods separately says the tobit model compares mean duration and that the **treatment effect estimate** is a difference in means.
- **Logical basis:** The D01 treatment-group cells contain a center plus two endpoints, not a mean followed by one SD. The supplement identifies the corresponding descriptive format for this outcome as median (IQR), while its Methods reserve `difference in means` for the model-based treatment effect. The main-table label conflates the group descriptive summaries with the scale of the model effect.
- **Critic rationale:** The document evidence supports a descriptive-label inconsistency without disputing the model-based mean difference. Because the displayed effect remains interpretable and the error is confined to labeling, it is Minor.
- **Verification instruction:** Compare the D01 p. 7 row label and treatment cells with the D04 p. 18 footer, then confirm on D04 p. 4 that `difference in means` refers to the modeled treatment effect; determine whether the D01 group-summary label should be `median (IQR)`.

### 6. Table 2 points eFigure 6 to Supplement 1 although it is in Supplement 3

- **Severity:** Minor
- **Category:** Presentation inconsistency
- **Exact location:** [D01, PDF p. 7, Table 2 footnote f](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7). Comparisons: [D01, PDF p. 4, Primary Outcome](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=4) and [D04, PDF p. 27, eFigure 6](../../joi250040supp3_prod_1753124024.38098.pdf#page=27).
- **Source values/statements:** Table 2 footnote f says, `Bayesian model diagram is shown in eFigure 6 in Supplement 1.` The Primary Outcome text places `eFigure 5 and eFigure 6` in `Supplement 3`. D04 is the supplied Supplement 3 and contains `eFigure 6: Bayesian model analysis` on p. 27.
- **Logical basis:** The Table 2 footnote's document locator conflicts with both the Results text and the actual location of eFigure 6 in the supplied Supplement 3.
- **Critic rationale:** This is a direct, document-grounded cross-reference error, but it does not affect any reported result. It is Minor.
- **Verification instruction:** Read footnote f on D01 p. 7, compare the Results cross-reference on D01 p. 4, and confirm the eFigure 6 heading on D04 p. 27; replace `Supplement 1` with `Supplement 3` if that is the intended target.

## Uncertain findings not accepted

### C06. Discussion calls day-10 urea concentrations means although the displayed summaries are medians (IQR)

- **Severity:** Uncertain
- **Proposed category:** Statistical reporting inconsistency
- **Locations:** [D01, PDF p. 8, Discussion](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=8); [D01, PDF p. 5, Biochemical Outcomes](../../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=5); [D04, PDF p. 19, eTable 11](../../joi250040supp3_prod_1753124024.38098.pdf#page=19).
- **Evidence considered:** The Discussion says `mean urea concentrations at day 10 were higher in the augmented protein group`. The Results and eTable 11 report medians (IQR): `13.0 (8.2-18.8)` versus `10.6 (7.1-15.4)` mmol/L.
- **Reason for uncertainty:** The documents establish that the displayed day-10 summaries are medians, but they do not establish that the Discussion sentence is numerically restating those displayed values rather than referring to unreported arithmetic means from the same observations. A distribution can have both a higher mean and a higher median. Therefore, the wording is suspicious and potentially imprecise, but the provided documents alone do not prove that `mean` is false or that the two statements are contradictory.
- **Human adjudication instruction:** If editorial source data or analysis output is available, check whether day-10 arithmetic means were calculated and compared. If not, treat `mean` as a terminology error and change it to `median`; otherwise, consider whether the corresponding mean values should be reported.

## Rejected findings

None. C06 was downgraded to `Uncertain` rather than rejected because the terminology mismatch is document-grounded, but its status as an actual reporting contradiction cannot be resolved from the supplied statements alone.
